These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38683882)

  • 1. Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol-associated liver disease.
    Hanai T; Nishimura K; Unome S; Miwa T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
    Hepatol Res; 2024 Nov; 54(11):1089-1098. PubMed ID: 38683882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
    Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Customized nutrition intervention and personalized counseling helps achieve nutrition targets in perioperative liver transplant patients.
    Daphnee DK; John S; Rajalakshmi P; Vaidya A; Khakhar A; Bhuvaneshwari S; Ramamurthy A
    Clin Nutr ESPEN; 2018 Feb; 23():200-204. PubMed ID: 29460799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis.
    Thanapirom K; Suksawatamnuay S; Wejnaruemarn S; Thaimai P; Siripon N; Ananchuensook P; Sriphoosanaphan S; Vanichanan J; Treeprasertsuk S; Poovorawan Y; Komolmit P
    Clin Transl Gastroenterol; 2024 May; 15(5):e00697. PubMed ID: 38488171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional support for liver disease.
    Koretz RL; Avenell A; Lipman TO
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for a case-control prospective study to investigate the impact of
    Towey J; Ngonadi C; Rajoriya N; Holt A; Greig C; Armstrong MJ
    BMJ Open Gastroenterol; 2022 Dec; 9(1):. PubMed ID: 36564096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Medical Treatment for Alcohol-Associated Liver Disease.
    Ayares G; Idalsoaga F; Díaz LA; Arnold J; Arab JP
    J Clin Exp Hepatol; 2022; 12(5):1333-1348. PubMed ID: 36157148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis.
    Bai Z; Bernardi M; Yoshida EM; Li H; Guo X; Méndez-Sánchez N; Li Y; Wang R; Deng J; Qi X
    Aging (Albany NY); 2019 Oct; 11(19):8502-8525. PubMed ID: 31596729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
    Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy.
    Idalsoaga F; Robles C; Ortiz A; Corsi O; Fuentes-López E; Díaz LA; Ayares G; Arrese M; Arab JP
    Therap Adv Gastroenterol; 2024; 17():17562848241254267. PubMed ID: 38812703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Tapper EB; Zhao L; Nikirk S; Baki J; Parikh ND; Lok AS; Waljee AK
    Am J Gastroenterol; 2020 Dec; 115(12):2017-2025. PubMed ID: 32773463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
    J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Riggio O; Amodio P; Farcomeni A; Merli M; Nardelli S; Pasquale C; Pentassuglio I; Gioia S; Onori E; Piazza N; De Rui M; Schiff S; Montagnese S
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1346-52. PubMed ID: 25572976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.